|
|
Optimal Management
of Dementia in "Senior America"
This program was presented
at a live symposium on November 12, 1999, at Senior
Care Pharmacy ’99, the 30th Annual Meeting
of the American Society of Consultant Pharmacists.
It was originally sponsored by Extension Services
in Pharmacy at the University of Wisconsin School
of Pharmacy, and was accredited for 1.0 hour (0.1
CEUs) under ACPE Universal Program # 073-999-99-106-L01.
If you attended the live symposium, you are not
eligible to receive continuing pharmaceutical education
credit through this program. This program was supported
by an educational grant from Janssen
Pharmaceutica Products, LP .
|
| This program
has been approved for 1.0 Contact
hours of CPE. Normal certificate processing takes
up to two weeks after successful completion of program
test. |
Click
here to begin the course
Target Audience
This symposium will be of interest to consultant pharmacists
who work with geriatrric patients. The program will provide
a clinical update on the management of dementia in the
elderly from the perspectives of the healthcare professional
and caregiver. In addition, the regulatory perspective
will be addressed regarding the interrelationships among
MDS (Minimum Data Set), Resident Assessment Instrument,
and the new HCFA guidelines, and ASCP’s MedGuide.
Achieving optimal patient care in our "managed cost"
environment will be discussed.
Learning
Objectives
Upon completion of this program, participants should
be able to: |
|
|
Identify
the issues surrounding the total care of the elderly
patient with psychosis. |
|
|
Summarize
the interrelationships among the various assessment
tools used to appropriately impact patient outcomes.
|
|
|
Describe
the optimal therapeutic interventions for the treatment
of the elderly patient with psychosis. |
|
|
Assess the
newest data concerning atypical antipsychotics with
respect to their efficacy and safety in the managed
cost environment. |
| Agenda |
Psychosis
and Noncognitive Behaviors in Dementia:
Professional and Caregiver Perspective
George T. Grossberg, MD |
|
|
Professor
Director of Geriatric Psychiatry
Department of Psychiatry
Saint Louis University School of Medicine |
Atypical
Antipsychotics Versus Older Neuroleptics in a Managed
Cost Environment
Harlan S Martin, RPh, CCP, FASCP |
|
|
President
and Founder
Pharma-Care, Inc. |
| Michael
P. Slyk, PharmD, FASCP |
|
|
President
and Founder
Pharmacotherapy Associates, Inc. |
Intervention
and Outcome
Michele A. Bender, MSN, RN, CS |
|
|
Psychiatric
Clinical Nurse Specialist
MetroHealth Medical Center and MetroHealth Center
for Skilled
Nursing Care |
Multidisciplinary Team
Approach Case Study
Panel Discussion
 |
This
program is cosponsored by the American Society of
Consultant Pharmacists and Estension Services in Pharmacy
at the University of Wisconsin School of Pharmacy.
The American Society of Consultant Pharmacists and
Extension Services in Pharmacy at the University of
Wisconsin are approved by the American Council on
Pharmaceutical Education as a provider of continuing
pharmaceutical education. This program is approved
for 1.0 contact hour (0.1 CEUs) of continuing education
credit. ACPE Universal Program #073-203-99-106-H01.
Program Date: November 12, 1999. This program is valid
through November 22, 2002. |
This program was developed
by SENIORX SOLUTIONS™ and supported by an
educational grant from Janssen Pharmaceutica Products,
LP.
|
